Ceapro Announces Results of 2023 Shareholders' Meeting

EDMONTON, Alberta, June 07, 2023 -- Ceapro Inc. , a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic... | June 7, 2023

Related Keywords

Canada ,Canadian ,William Li ,Jenene Thomas ,Ulrich Kosciessa ,Glenn Rourke ,Ronaldw Miller ,Gilles Gagnon ,Gillesr Gagnon ,Corporate Communications Advisor ,Ceapro Inc ,Annual General ,Special Meeting ,Stock Option Plan ,Corporate Communications ,Ceapro Inc Stock Exchange ,News ,Information ,Press Release ,Pune ,023 ,Seapro ,Biotechnology ,Company ,Ocused ,N ,The ,Development ,End ,Ommercialization ,F ,Ctive ,Ingredients ,Or ,Healthcare ,Nd Czo Ca1499071076 ,